Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) stock has moved in a downward direction over the past week, yielding losses for investors. Based on the recent close, the shares have dropped -6.01% over the past five trading days. Looking further out, the stock is 7.28% year to date. With increased market volatility, stakeholders will likely be deciding whether or not now is a good time to cut losses or double down on the pullback.
Wall Street analysts are still seeing some upside to the stock despite the recent move. Sell-side firms, on a consensus basis have a $212.84 price target on the name and a 2.30 recommendation, according to First Call. The recommendation is based on a 1 to 5 scale where 1 or 2 indicates a Buy recommendation, 3 a Hold and 4-5 a Sell.
In taking a look at technical levels, shares are trading 0.18% away from the 50 day simple moving average and 13.04% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -26.50% away from it’s 52- week high and 78.51% away from its 52 week low. After the recent increase, investors may also look to see if the stock has entered overbought territory and could possibly ripe for a pullback.
Traditionally a stock is considered to be overbought when the Relative Strength Index moves above 70. As of writing, Intercept Pharmaceuticals, Inc.’s RSI stands at 48.69 . In looking at volatility levels, the shares saw weekly volatility of 3.78% and 3.80% over the past month.
Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts.
Intercept Pharmaceuticals, Inc. - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.